Guidelines for Writing Outcome
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Issues And Trends In Healthcare Delivery System
Nursing Evaluation
Current Trends in Nursing II
The Scientific Method in Nursing Process
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 18, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Pooyeh Graili1, Luciano Ieraci2,3, Nazanin Hosseinkhah1
1Quality HTA (Quality Health Technology Assessment), Oakville, ON, Canada.
This review examines how artificial intelligence is currently applied to measure health outcomes. By analyzing 370 studies, the authors identify common uses, such as predicting treatment effectiveness and patient prognosis, particularly in cancer care. The findings highlight that while these tools show promise, decision-makers must carefully evaluate their integration into healthcare policy and technology assessment.
Area of Science:
Background:
No prior work had resolved the full extent of machine learning applications within the specific domain of patient-centered results. Systematic investigations often overlook the intersection between advanced computational models and health technology assessment frameworks. This gap motivated a comprehensive look at how digital tools influence the evaluation of medical interventions. Prior research has shown that automated systems are increasingly prevalent across general clinical settings. However, the specific utility of these models for measuring therapeutic or preventive success remains poorly defined. That uncertainty drove the need to map current practices in this specialized field. Researchers have previously focused on broad medical applications rather than the rigorous metrics required for policy decisions. This study addresses the lack of synthesized evidence regarding the deployment of algorithmic techniques in outcomes-based research.
Purpose Of The Study:
The aim of this study is to systematically map the scope of advanced computational methods currently utilized in outcomes research. This investigation addresses the lack of clarity regarding how these tools support health technology assessment. The researchers seek to enhance the knowledge base available to decision-makers tasked with evaluating medical interventions. By clarifying the current landscape, the team hopes to broaden perspectives on the adoption of automated systems. The study specifically targets the intersection of algorithmic prediction and the measurement of therapeutic, preventive, or prognostic results. This work is motivated by the need to understand how these technologies influence the cornerstone of healthcare policy. No prior work had resolved the full extent of these applications across diverse medical fields. The authors intend to provide a foundation for more informed decision-making processes in the future.
Main Methods:
The review approach involved a systematic scoping methodology to identify relevant literature. Investigators searched databases for studies focusing on machine learning applications in adult patient populations. The team included research reporting therapeutic, preventive, or prognostic results from any medical intervention. This design ensured a broad capture of computational techniques currently utilized in the field. Reviewers extracted data regarding specific algorithms and the clinical contexts of each identified publication. The process prioritized studies that explicitly linked automated models to the evaluation of patient-centered success. This structured protocol allowed for the categorization of diverse algorithmic approaches across various healthcare sectors. The final dataset comprised 370 individual papers that met all predefined inclusion criteria for the analysis.
Main Results:
Key findings from the literature indicate that predictive analysis serves as the most common application for assessing treatment effectiveness. The review identified 370 studies that utilized automated models to evaluate patient outcomes. Predictive modeling appeared most frequently in research concerning neoplastic disorders. Neural networks represented the dominant algorithm found within the subset of surgical intervention studies. A diverse mixture of computational algorithms was applied to research involving other types of medical interventions. The data show that morbidity outcomes are the primary focus for these automated predictive techniques. These results highlight a clear trend toward using advanced models for prognosis and effectiveness measurement. The synthesis confirms that algorithmic usage is currently concentrated in specific therapeutic areas rather than being evenly distributed.
Conclusions:
The authors suggest that significant voids exist in the current application of machine learning across diverse therapeutic fields. Decision-makers should exercise caution before integrating these automated tools into formal health technology assessment protocols. The evidence indicates that current algorithmic usage is not uniform across all medical interventions. Future policy development requires a deeper understanding of how these models influence clinical decision-making processes. The researchers propose that a more nuanced evaluation of predictive accuracy is necessary for widespread adoption. Synthesis of the literature reveals that while potential exists, current implementation remains fragmented. The team emphasizes that stakeholders must prioritize transparency when utilizing these computational methods for patient care. These findings provide a foundation for improving the quality of evidence used in healthcare technology evaluations.
The researchers propose that these tools primarily function by performing predictive analysis for patient prognosis and treatment effectiveness. This mechanism allows for the estimation of therapeutic success, particularly within morbidity-related data, which contrasts with traditional statistical methods that often rely on simpler linear modeling approaches.
The study identifies neural networks as the most frequently employed algorithm within surgical intervention research. This specific architecture is often contrasted with the broader, mixed array of machine learning models applied to non-surgical medical interventions, which demonstrate greater algorithmic diversity.
The authors suggest that rigorous evaluation of these models is necessary before they are incorporated into health technology assessment. This requirement exists because current applications show inconsistent coverage across different therapeutic areas, necessitating a cautious approach compared to established, non-automated assessment standards.
The researchers utilized data from 370 distinct studies to map the landscape of algorithmic usage. This collection of literature serves as the primary evidence base, allowing the team to categorize findings by intervention type and clinical outcome rather than relying on individual trial results.
The study measured the prevalence of predictive analysis in neoplastic disorders. This phenomenon was observed more frequently in cancer-related research than in other medical fields, highlighting a specific concentration of advanced computational efforts within oncology compared to general preventive medicine.
The authors propose that decision-makers must broaden their perspectives on technology adoption. They argue that understanding the current scope of these methods is a prerequisite for improving the quality of evidence used in healthcare policy, rather than simply adopting new tools without critical appraisal.